Lugano, Switzerland, 6 June 2024 – The ESMO Gynaecological Cancers Congress 2024 will be held in Florence, Italy, between 20-22 June, hosting international experts who will present and discuss the latest developments in the biology, diagnosis and therapy of gynaecological tumours. The management of rare gynaecological malignancies will be among the key areas covered in the scientific programme, available online.
Lugano, Switzerland, 6 June 2024 – The ESMO Gynaecological Cancers Congress 2024 will be held in Florence, Italy, between 20-22 June, hosting international experts who will present and discuss the latest developments in the biology, diagnosis and therapy of gynaecological tumours. The management of rare gynaecological malignancies will be among the key areas covered in the scientific programme, available online.
The congress can be joined either in person or via the online platform.
Programme highlights
- Promising approach in the management of patients with rare gynaecological tumours within the European Reference Network for Rare Adult Solid Cancers (EURACAN).
- Related content: 82MO
- Encouraging results to transform the therapeutic landscape in advanced cervical cancer.
- Promising novel targets for ADC treatment in cervical and ovarian cancer.
- New genetic insights to provide personalised care in patients with gynaecological malignancies.
Keynote Lecture
- “10 years of success in gynaecological malignancies treatment: Moving forward into a brilliant future” by Giovanna Scambia, 21 June 2024, 12:00-12:30 CEST.
The results of 89 studies will be presented and published online as a supplement to ESMO Open.
Press accreditation
ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities. To apply for press accreditation, please fill out the form available here. Requests for press accreditation should be sent by Wednesday, 19 June. Please be kindly informed that onsite press accreditation will not be possible.
Third Parties Media registration
Third Parties Media representatives and Filming Crews not eligible as press, must abide by the ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through registration@esmo.org (Cc media@esmo.org).
Further information
ESMO Press Office
press@esmo.org
Notes to editors
Please make sure to use the official name of the meeting in your reports: ESMO Gynaecological Cancers Congress 2024 and the official congress hashtag #ESMOGynae24. Follow it to stay up to date and use it to take part in the conversation on X(Twitter), LinkedIn, Facebook, Instagram, YouTube.
About the European Society for Medical Oncology (ESMO)
Representing more than 35,000 oncology professionals from 172 countries worldwide, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. www.esmo.org
